SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-17-001556
Filing Date
2017-02-17
Accepted
2017-02-17 16:32:26
Documents
10
Period of Report
2017-03-29
Effectiveness Date
2017-02-17

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def14a0217_chinajojodrugs.htm DEF 14A 470488
2 GRAPHIC image_001.jpg GRAPHIC 1375
3 GRAPHIC image_002.jpg GRAPHIC 1137
4 GRAPHIC image_003.jpg GRAPHIC 1086
5 GRAPHIC image_004.jpg GRAPHIC 1281
6 GRAPHIC img_005.jpg GRAPHIC 10999
7 GRAPHIC img_001.jpg GRAPHIC 2490
8 GRAPHIC img_002.jpg GRAPHIC 2007
9 GRAPHIC img_003.jpg GRAPHIC 1823
10 GRAPHIC img_004.jpg GRAPHIC 3080
  Complete submission text file 0001213900-17-001556.txt   507752
Mailing Address 1ST FLOOR, YUZHENG PLAZA YUHUANGSHAN ROAD, HANGZHOU CITY ZHEJIANG PROVINCE F4 310008
Business Address 1ST FLOOR, YUZHENG PLAZA YUHUANGSHAN ROAD, HANGZHOU CITY ZHEJIANG PROVINCE F4 310008 (86) 1501-158-6601
CHINA JO-JO DRUGSTORES, INC. (Filer) CIK: 0001413263 (see all company filings)

IRS No.: 980557582 | Fiscal Year End: 0730
Type: DEF 14A | Act: 34 | File No.: 001-34711 | Film No.: 17621819
SIC: 2833 Medicinal Chemicals & Botanical Products